These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 35065994)
1. Descriptive analysis of the relationship between progesterone and basal body temperature across the menstrual cycle. Écochard R; Leiva R; Bouchard T; Boehringer H; Iwaz J; Plotton I Steroids; 2022 Feb; 178():108964. PubMed ID: 35065994 [TBL] [Abstract][Full Text] [Related]
2. Monitoring of ovarian activity by measurement of urinary excretion rates using the Ovarian Monitor, Part IV: the relationship of the pregnanediol glucuronide threshold to basal body temperature and cervical mucus as markers for the beginning of the post-ovulatory infertile period. Blackwell LF; Vigil P; Alliende ME; Brown S; Festin M; Cooke DG Hum Reprod; 2016 Feb; 31(2):445-53. PubMed ID: 26677961 [TBL] [Abstract][Full Text] [Related]
3. Urinary progesterone and pregnanediol. Use for monitoring progesterone treatment. Stanczyk FZ; Gentzschein E; Ary BA; Kojima T; Ziogas A; Lobo RA J Reprod Med; 1997 Apr; 42(4):216-22. PubMed ID: 9131494 [TBL] [Abstract][Full Text] [Related]
4. Detecting evidence of luteal activity by least-squares quantitative basal temperature analysis against urinary progesterone metabolites and the effect of wake-time variability. Bedford JL; Prior JC; Hitchcock CL; Barr SI Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):76-80. PubMed ID: 19552997 [TBL] [Abstract][Full Text] [Related]
5. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles. Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744 [TBL] [Abstract][Full Text] [Related]
6. Relationships between the luteinizing hormone surge and other characteristics of the menstrual cycle in normally ovulating women. Direito A; Bailly S; Mariani A; Ecochard R Fertil Steril; 2013 Jan; 99(1):279-285.e3. PubMed ID: 22999798 [TBL] [Abstract][Full Text] [Related]
7. Correlation between urinary pregnanediol glucuronide and basal body temperature in female orangutans, Pongo pygmaeus. Asa CS; Fischer F; Carrasco E; Puricelli C Am J Primatol; 1994; 34(3):275-281. PubMed ID: 31936964 [TBL] [Abstract][Full Text] [Related]
8. Direct measurement of pregnanediol 3-glucuronide (PDG) in dried urine spots by liquid chromatography-mass spectrometry to detect ovulation. Handelsman DJ; Nimmagadda R; Desai R; Handelsman TD; Whittle B; Skorupskaite K; Anderson RA J Steroid Biochem Mol Biol; 2021 Jul; 211():105900. PubMed ID: 33872762 [TBL] [Abstract][Full Text] [Related]
9. Postpartum return of ovarian activity in nonbreastfeeding women monitored by urinary assays. Gray RH; Campbell OM; Zacur HA; Labbok MH; MacRae SL J Clin Endocrinol Metab; 1987 Apr; 64(4):645-50. PubMed ID: 3818896 [TBL] [Abstract][Full Text] [Related]
10. Identification of anovulation and transient luteal function using a urinary pregnanediol-3-glucuronide ratio algorithm. Kassam A; Overstreet JW; Snow-Harter C; De Souza MJ; Gold EB; Lasley BL Environ Health Perspect; 1996 Apr; 104(4):408-13. PubMed ID: 8732951 [TBL] [Abstract][Full Text] [Related]
11. Pilot Evaluation of a New Urine Progesterone Test to Confirm Ovulation in Women Using a Fertility Monitor. Bouchard TP; Fehring RJ; Schneider M Front Public Health; 2019; 7():184. PubMed ID: 31312631 [No Abstract] [Full Text] [Related]
12. Use of urinary pregnanediol 3-glucuronide to confirm ovulation. Ecochard R; Leiva R; Bouchard T; Boehringer H; Direito A; Mariani A; Fehring R Steroids; 2013 Oct; 78(10):1035-40. PubMed ID: 23831784 [TBL] [Abstract][Full Text] [Related]
13. The Fertility Indicator Equation Using Serum Progesterone and Urinary Pregnanediol-3-Glucuronide for Assessment of Ovulatory to Luteal Phase Transition. Usala SJ; Alliende ME; Trindade AA Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33546226 [No Abstract] [Full Text] [Related]
14. The prediction and/or detection of ovulation by means of urinary steroid assays. Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775 [TBL] [Abstract][Full Text] [Related]
15. Progesterone and ovulation across stages of the transition to menopause. O'Connor KA; Ferrell R; Brindle E; Trumble B; Shofer J; Holman DJ; Weinstein M Menopause; 2009; 16(6):1178-87. PubMed ID: 19568209 [TBL] [Abstract][Full Text] [Related]
16. Definition of the potentially fertile period from urinary steroid excretion rates. Part II. A threshold value for pregnanediol glucuronide as a marker for the end of the potentially fertile period in the human menstrual cycle. Blackwell LF; Brown JB; Cooke D Steroids; 1998 Jan; 63(1):5-13. PubMed ID: 9437789 [TBL] [Abstract][Full Text] [Related]
17. Use of the Home Ovarian Monitor in pregnancy avoidance. Brown JB; Holmes J; Barker G Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2008-11. PubMed ID: 1755460 [TBL] [Abstract][Full Text] [Related]
18. Pilot observational prospective cohort study on the use of a novel home-based urinary pregnanediol 3-glucuronide (PDG) test to confirm ovulation when used as adjunct to fertility awareness methods (FAMs) stage 1. Leiva R; McNamara-Kilian M; Niezgoda H; Ecochard R; Bouchard T BMJ Open; 2019 May; 9(5):e028496. PubMed ID: 31133596 [TBL] [Abstract][Full Text] [Related]
19. Hormonal Predictors of Abnormal Luteal Phases in Normally Cycling Women. Abdulla SH; Bouchard TP; Leiva RA; Boyle P; Iwaz J; Ecochard R Front Public Health; 2018; 6():144. PubMed ID: 29881719 [No Abstract] [Full Text] [Related]
20. Basal body temperature: unreliable method of ovulation detection. Bauman JE Fertil Steril; 1981 Dec; 36(6):729-33. PubMed ID: 7308516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]